Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
Turbo Cancers Exploding in Young People from mRNA COVID Vaccines | Dr. William Makis
Shocking testimony from Canadian doctor and cancer researcher Dr. William Makis: After diagnosing thousands of patients over decades, he’s witnessing aggressive “turbo cancers” in young adults (20s-40s) that he’s “never seen anything like this” or “never seen cancers behaving like this.” These cancers present as: Rapid, explosive growth; Late-stage (e.g., stage 4) in unusually young […]
Closing the Deal: The Misinforming of the G20 on Pandemics
The G20’s High Level Independent Panel (HLIP) on pandemic preparedness convened through 2025 to provide a report entitled Closing the Deal: Financing our Security Against Pandemic Threats to the November G20 Leaders’ Summit in South Africa. The report was as a follow-up to the HLIP’s 2022 report on A Global Deal for our Pandemic Age […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended
On Feb. 18, 2026, the U.S. Food and Drug Administration (FDA) agreed to review Moderna’s application for its mRNA influenza shot, known as mRNA-1010, after the company amended its submission to address regulatory concerns. The agency accepted the updated biologics license application and set a target action date of Aug. 5, 2026, allowing the shot […]